Pfizer Sales Forecast, Ford EV Pivot, and Roku Upgrade: Stock Movers

Pfizer's 2026 Revenue Outlook

• 📉 Pfizer's shares reacted negatively to a lowered 2026 revenue guidance, with the midpoint now below Wall Street consensus.
• 💰 The company forecasts 2026 revenue between $59.5 billion and $62.5 billion, compared to an estimate of $61.3 billion.
• 💡 Pfizer is aiming to deliver a majority of its pledged cost savings by 2026 and has recently made acquisitions in the obesity space.
• ⚠️ The drugmaker has faced challenges managing the decline in COVID-19 product revenue.

Ford's EV Strategy Shift

• 📈 Ford shares rose following the announcement of a significant charge related to its electric vehicle business overhaul.
• 🚗 Ford is taking a nearly $20 billion charge, pivoting from large-format EVs to more hybrid vehicles, including converting planned electric F-series trucks to extended-range hybrids.
• 💰 This strategic shift aims to make Ford's EV operations profitable by 2029 and has led to a boosted 2025 guidance.

Roku's Analyst Upgrade

• 🚀 Roku's stock increased after Morgan Stanley upgraded the streaming platform to overweight from underweight.
• 📊 The upgrade cites Roku's dominant market share in US streaming, leading to a better outlook for its advertising revenue.

European Defense Sector Decline

• 🪖 The European defense sector, including Rheinmetall, saw declines, with Rheinmetall down 4.6%.
• 🕊️ This downturn follows more positive comments regarding the end of the Russia-Ukraine war.
• 📈 Despite recent drops, many defense stocks remain significantly up year-to-date.